OpenLegislation

Paragraph 16 I1

United Kingdom

After Schedule 2 insert—

“SCHEDULE 3

Maximum residue level supplementary information fees F1chargeable by a Great Britain competent authority

Regulation 4(2A)

Fees chargeable by a Great Britain competent authority for the evaluation of supplementary information provided in accordance with Article 14(3) of the MRL Regulation are in accordance with the following table.

ItemCategoryFee (£)
1Preliminary consideration of application to determine whether the application can proceed further229
2Co-ordination of applications1,872
3Simple reasoned case(1)416
4Analytical method(2)416
5Toxicology(3)3,120
6Metabolism and residues evaluation(4)6,760
7Residues evaluation(5)2,028

Notes

(1)

This category is for an MRL supplementary information requirement to provide additional information on aspects of the data already evaluated or to provide evidence of the commercial availability of standards for MRL compliance.

(2)

This category is for an MRL supplementary information requirement to provide an analytical method for MRL compliance.

(3)

This category is for an MRL supplementary information requirement to address the toxicological relevance of a metabolite identified in plants or products of animal origin.

(4)

This category is for an MRL supplementary information requirement to address plant or livestock metabolism or any other nature of residue study.

(5)

This category is for an MRL supplementary information requirement to provide additional residue trials or any other magnitude of residue study including monitoring data.

Fees for multiple submissions to address MRL supplementary information for the same active substance are calculated on a modular basis with a charge applied for each MRL supplementary information requirement. Large or novel studies to address MRL supplementary information requirements will incur an additional fee, as a multiple of the original fee, if significant extra work is required over and above the usual level for the module in question.”

Annotations

Textual amendments

F1

Words in Sch. 1 para. 16 inserted (31.12.2020 immediately before IP completion day) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1567), reg. 1(2), Sch. 1 para. 12

Commencement

I1

Sch. 1 para. 16 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)